🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of elezanu...
Status
Completed
Location
St. Josephs Hospital and Med Center /ID# 202809
Start Date
2019-02-27
Trial ID
NCT03737812
Treatments Being Tested
Multiple Sclerosis Functional Composite score (MSFC) is one of the gold sta...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02814487
Transitioning from a sitting to a standing position is a movement essential...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-28
Trial ID
NCT06648499
This clinical trial compares the relative efficacy of treating acute exacer...
Status
Terminated
Location
University of Medicine and Dentistry of New Jersey
Start Date
2003-09
Trial ID
NCT00418145
Treatments Being Tested
This was an observational retrospective cohort study using electronic medic...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2022-10-11
Trial ID
NCT06526000
Pediatric Multiple sclerosis (MS) is a chronic inflammatory disease defined...
Status
Unknown
Location
Universidade Federal de Uberlândia
Start Date
2017-03-01
Trial ID
NCT03087136
Treatments Being Tested
This study is a prospective, randomized, double-blind, placebo-controlled e...
Status
Completed
Location
The University of Texas Health Science Center
Start Date
2009-12
Trial ID
NCT01031901
Treatments Being Tested
Tuberous Sclerosis Complex (TSC) is a multi-system disease, usually present...
Status
Completed
Location
Boston Children's Hospital
Start Date
2011-01
Trial ID
NCT01289912
The study involves MS patients with and without neuropsychological disorder...
Status
Completed
Location
St Vincent hospital - neurological service
Start Date
2021-05-21
Trial ID
NCT04837365
Treatments Being Tested
This is a Phase 1, single-center, open-label, adaptive-design PET study to ...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2021-09-01
Trial ID
NCT04941781
Treatments Being Tested